ROCHE GS
Viés de alta

Hold it like a rock - Roche, what an opportunity.

Hi, 1PERCENT here.

Roche Holding, a Swiss multinational biopharma company. It is like the Apple of biopharma.

There were only 3 pull backs greater than 30% in the history of the stock.

2002 ~ 2003: -45.33%
2006 ~ 2011: -52.40%
2014 ~ 2018: -30.24%
2022 ~ present: -44.89%

It is at the support zone that initiated the +95% move up from 2018 to 2022, and also is testing the trendline connecting the lows in 2003 and 2011.

If you live in the US, you might want to have some exposure to Swiss assets (CHF or stocks) and Gold & silver.
captura

The US dollar is losing value against the Swiss Francs in the long term.

Otherwise, Roche stock price must hold up at the current support zone, otherwise, we are open for a 30+% drop to the next support zone, which will be of course, an absolute bargain.

Also, it looks like the previous turnovers from the lows were always accompanied by the MA36 and MA12 crossing (MA12 over MA36)

However, we do not have it here yet. So, let's keep an eye on it.

That's it.
1PERCENT
biopharmabiotechFractalrocherocheholdingROGSupport and Resistance

✅ Follow me on X
- twitter.com/1percent_kr
✅ 더욱 잦은 업데이트는 아래 링크에서!
- t.me/+7mIBvloUd0k3NWQ9
✅ 시황 코멘트와 다양한 투자 관련 분석은 유튜브 채널에서!
- youtube.com/c/1PERCENTKOREA
✅ 미국주식, 국내주식 등 다양한 정보 공유
- blog.naver.com/onepercentkr
Também em:

Publicações relacionadas

Aviso legal